Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial Meeting Abstract
| Authors: | Dang, C.; Ewer, M. S.; Delaloge, S.; Ferrero, J. M.; Colomer, R.; Merino, L. D.; Dadswell, K.; Verrill, M.; Eiger, D.; Sarkar, S.; de Haas, S.; Restuccia, E.; Swain, S. M. |
| Abstract Title: | Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial |
| Meeting Title: | ESMO Breast Cancer Virtual Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 May 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-05-01 |
| Start Page: | S38 |
| End Page: | S39 |
| Language: | English |
| ACCESSION: | WOS:000648924400044 |
| DOI: | 10.1016/j.annonc.2021.03.057 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 43O -- Source: Wos |
